查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球醫療美容市場（按產品/設備類型、治療類型、最終用戶、性別、分銷管道、主要地區）：行業趨勢和預測
市場調查報告書
商品編碼
1411403

全球醫療美容市場（按產品/設備類型、治療類型、最終用戶、性別、分銷管道、主要地區）：行業趨勢和預測

Medical Aesthetics Market - Distribution by Type of Product and / or Device Offered, Type of Procedure, End User, Gender, Distribution Channel, and Key Geographical Regions : Industry Trends and Global Forecasts
出版日期: | 出版商: Roots Analysis | 英文 294 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

2023年，全球醫學美容市場價值為350億美元，在預測期（2023-2035年）複合年增長率為9.3%。

我們認為，近年來對醫美解決方案的需求增加是由於多種因素造成的，包括保持年輕外表的願望、社交媒體的影響、技術進步、名人代言以及美容師和醫療專業人士的支持。你可以COVID-19 大流行也大大促進了每年美容治療手術數量的增加。根據國際美容整形外科學會（ISAPS）的一項研究，2022年全球將進行超過1500萬例侵入性美容手術和1900萬例非侵入性美容手術。儘管該行業近90%的客戶是女性，但美容醫學在男性中也越來越受歡迎。推動男性美容市場成長的趨勢與推動女性美容市場成長的趨勢相同，包括對自然效果的渴望、微創手術以及對外觀意識的提高。

由於這些手術的高需求，醫美公司開發了醫療產品和設備。醫美公司的主要興趣在於開發非手術或微創解決方案。最常見的微創治療包括肉毒桿菌和美容填充劑。這些療程主要用於改善正常線條和收緊皮膚。然而，美容療程的好處不僅限於美容；它們還可以幫助解決其他常見的醫療問題。肉毒桿菌用於減少出汗和偏頭痛。身體輪廓設備、雷射除毛、去除紋身和指甲治療是一些常見的非手術治療方法。塑形儀用於收緊皮膚、減少脂肪、減少脂肪團。

可以在醫療美容診所和醫療水療中心接受醫療美容治療。目前醫療美容市場70%以上由醫院、診所、醫療水療中心營運。此外，韓國作為世界整容中心，也是人均整容手術數量最多的國家。這要歸功於完善的整容手術基礎設施和熟練的醫療專業人員，他們鼓勵韓國整容醫療旅遊。一個主要問題是一些醫療專業人員和醫學美容公司違反了監管準則，這可能會導致副作用。透過克服這些挑戰並應對日益增長的醫美服務需求，醫美公司預計將在未來幾年實現顯著成長。

本報告分析了全球醫療美容市場，並提供了治療概述、市場的基本結構和最新情況、主要市場促進和限制因素、整體市場規模趨勢展望以及按細分市場和地區細分（所有5 個我們調查詳細區域市場趨勢、近期主要業務聯盟和資本交易動向（投資、併購等）、當前競爭狀況以及主要公司概況。

主要細分市場

依提供的產品/設備類型

  • 肉毒桿菌毒素
  • 真皮填充劑
  • 化學換膚
  • 輪廓
  • 臀部植入物
  • 脫髮
  • 乳房植入物
  • 其他產品/設備

按治療類型

  • 非侵入性
  • 微創
  • 侵入式

最終用戶

  • 醫院
  • 診所/醫療水療中心、皮膚/美容中心
  • 其他最終用戶

按性別

  • 男性
  • 女士

按銷售管道

  • 直銷
  • 間接銷售

按主要地區

  • 北美
  • 歐洲
  • 亞太地區
  • 中東/北非
  • 拉丁美洲

在這份報告中，

主要市場參與者

  • ADSS
  • Allergan Aesthetics
  • Astiland, Beijing Kes Biological Technology
  • BTL Aesthetics
  • Candela Medical
  • Classys
  • Croma Pharma
  • Cynosure
  • Daeyang Medical
  • Establishment Labs
  • Galderma
  • Guangzhou Itech Aesthetics
  • IBSA
  • Lumenis
  • Lutronic
  • MedicalZone
  • Mentor
  • Sanhe Medical
  • Shanghai Haohai Biological Technology
  • Sinclair Pharma
  • Sincoheren
  • Skin Tech Pharma
  • Wontech
  • Zesay Beauty

目錄

第一章簡介

第二章研究方法

第三章 經濟趨勢和其他項目特定考慮因素

第 4 章執行摘要

第 5 章 簡介

  • 醫學美容理念
  • 醫美的演變
  • 醫美的種類
  • 醫美的好處
  • 醫美副作用
  • 主要成長動力
  • 醫療美容最新技術
  • 醫療美容面臨的主要挑戰
  • 未來展望

第六章 市場狀況

  • 醫美企業：市場現狀

第七章公司簡介

  • 主要公司簡介
  • 其他公司概況

第八章企業競爭力分析

  • 主要先決條件和參數
  • 調查方法
  • 醫美：企業競爭力分析

第 9 章 夥伴關係與合作

  • 合作模式
  • 醫學美學：夥伴關係與合作
  • 區域分析

第十章 融資與投資

  • 融資模式
  • 醫療美容：融資與投資
  • 結論

第11章 DELT分析

  • 調查方法
  • 主要參數
  • 醫美：DELT分析
  • 結論

第十二章市場影響分析：促進因素、限制因素、機會與挑戰

  • 市場驅動力
  • 市場製約因素
  • 市場機會
  • 市場挑戰
  • 結論

第十三章 全球醫美市場

  • 主要假設及研究方法
  • 全球醫美市場：過去趨勢（2018-2022）與未來預測（2023-2035）
  • 主要細分市場
  • 動態儀表板

第十四章醫療美容市場：依提供的產品/設備類型分類

  • 主要假設及研究方法
  • 醫療美容市場：依提供的產品/設備類型劃分（2018、2023、2035）
  • 數據測量和驗證

第十五章醫療美容市場：依治療類型

  • 主要假設及研究方法
  • 醫療美容市場：依治療類型劃分（2018年、2023年、2035年）
  • 數據測量和驗證

第十六章醫療美容市場：依最終用戶分類

  • 主要假設及研究方法
  • 醫療美容市場：依最終用戶劃分（2018、2023、2035）
  • 數據測量和驗證

第十七章 醫療美容市場：依性別分類

  • 主要假設及研究方法
  • 醫療美容市場：依性別劃分（2018、2023、2035）
  • 數據測量和驗證

第十八章醫療美容市場：依分銷管道劃分

  • 主要假設及研究方法
  • 醫療美容市場：依分銷管道劃分（2018、2023、2035）
  • 數據測量和驗證

第十九章 醫療美容市場：依主要地區

  • 主要假設及研究方法
  • 醫療美容市場：依主要地區劃分（2018、2023、2035）
  • 數據測量和驗證

第二十章 醫美產品市場

  • 主要假設及研究方法
  • 全球醫療美容產品市場：過去趨勢（2018-2022）與未來預測（2023-2035）
  • 數據測量和驗證

第21章管理見解

第22章結論

第23章附錄1：表格數據

第二十四章 附錄2：公司與組織名單

簡介目錄
Product Code: RA100467

The medical aesthetics market is valued at USD 35 billion in 2023 growing at a CAGR of 9.3% during the forecast period 2023-2035.

The growing demand for medical aesthetic solutions in recent years can be attributed to various factors, including the desire to maintain a youthful appearance, the influence of social media, technological advancements, celebrity endorsements, and the support of beauticians and medical professionals. The COVID pandemic has also contributed significantly towards the increased number of annual aesthetic treatments. Medical aesthetics is a well-established branch of modern medicine that primarily focuses on enhancing the cosmetic appearance of an individual without clinical surgery. These treatments are mainly used for anti-aging purposes by reducing fine lines and wrinkles, lifting flabby skin, and skin rejuvenation. Medical aesthetic procedures can also help in reducing excess fat and cellulite, unwanted hair, and spider veins. According to a study conducted by the International Society of Aesthetic Plastic Surgery (ISAPS), over 15 million invasive aesthetic procedures and 19 million non-invasive aesthetic procedures have been performed globally in 2022. It is worth mentioning that nearly 90% of the industry clientele are women, however, these aesthetic procedures are also gaining popularity among men. In fact, men have shown an increased interest in the majority of major surgical and nonsurgical procedures, with the top cosmetic surgical procedures for men being rhinoplasty, eyelid surgery, cheek implant, breast reduction, liposuction, tummy tuck, and ear surgery. The reasons behind the growth of the male aesthetic market tend to be the same as those that have led to the growth of the female aesthetic market, including the desire for natural-looking results, minimally invasive procedures, and increased awareness of appearance.

Due to the high demand for these procedures, medical aesthetics companies have developed medical aesthetics products & devices. The main focus of medical aesthetics companies is to develop non-surgical or minimally invasive solutions. The majority of these treatments don't require a full surgical procedure. This means less pain and discomfort, fewer risks, shorter hospital stays, and long-lasting results. Some of the most common minimally invasive treatments are Botulism toxins and aesthetic filler. These treatments are mainly used for improving glabellar lines and tightening the skin. However, the advantages of aesthetic treatments aren't only cosmetic. They also help in solving other common healthcare problems. Botulism toxin is used to control sweating and migraines. Body contouring devices, laser hair removal, tattoo removal, and nail treatments are some of the other common non-surgical treatments. Body contouring devices are used for tightening the skin, reducing fat, and reducing cellulite.

Medical aesthetics treatments can be performed at a medical aesthetic clinic or at a medical spa. Dermatologists, plastic surgeons, doctors, nurse practitioners, registered nurses and aestheticians are among the medical professionals who can provide medical aesthetics treatments. It is interesting to note that more than 70% of the present medical aesthetics market is managed by hospitals, clinics and medical spas. In addition, South Korea, the plastic surgery capital in the world, is the country with the highest cosmetic surgeries per capita. This is because of the well-established cosmetic surgery infrastructure and the skilled medical professionals who encourage aesthetics medical tourism to South Korea. The main concern is that some medical professionals and the medical aesthetics companies are violating the regulatory guidelines, which can lead to side-effects. Therefore, it is extremely important for the patient to undergo medical aesthetics treatment by a licensed medical professional, using certified aesthetic devices, to avoid any such risks and complications. By overcoming these obstacles and meeting the increasing demand for medical aesthetics services, medical aesthetics companies are projected to see tremendous growth in the coming years.

Key Market Segments

Type of Product and / or Device Offered

  • Botulinum Toxin
  • Dermal Fillers
  • Chemical Peels
  • Body Contouring
  • Gluteal Implants
  • Hair Removal
  • Breast Implants
  • Other Products / Devices

Type of Procedure

  • Non Invasive
  • Minimally Invasive
  • Invasive

End User

  • Hospitals
  • Clincs / Med Spas and Dermatology / Cosmetology Centers
  • Other end users

Gender

  • Male
  • Female

Distribution Channel

  • Direct Distribution
  • Indirect Distribution

Key Geographical Regions

  • North America
  • Europe
  • Asia-Pacific
  • Middle East and North Africa
  • Latin America

Research Coverage:

The report studies the medical aesthetics market based on type of product and / or device offered, type of procedure, end user, gender, distribution channel, and key geographical regions

The report assesses the potential advantages and obstacles within the market for those involved and offers information on the competitive environment for top players in the market.

The report forecasts the revenue of market segments with respect to five major regions

The report provides an overview of medical aesthetics, including its evolution, types, and application areas. It also covers the benefits of these procedures compared to traditional beauty treatments and the side effects associated with them. The chapter also covers the key drivers of growth, new technologies, key issues and future prospects in this field.

Comprehensive analysis of the current landscape of medical aesthetics developers considering parameters such as establishment year, company size, headquarters, type of offering (product and / or device), type of products and / or devices offered, application area, type of procedure and end user

In-depth profiles of companies offering medical aesthetic procedures products and / or devices, focusing on company overviews, financial information (where available), offered medical aesthetic procedures, recent advancements, and informed future prospects.

Detailed company competitiveness evaluation of medical aesthetics company, considering supplier strength in terms of type of offering, type of product and / or device offered and type of procedure, and number of end users served.

An analysis of partnerships established in this sector since 2018, covering merger and acquisition, distribution, commercialization, licensing, supply, product development, product and technology integration and manufacturing agreements.

A comprehensive examination of funding and investments made in medical aesthetics companies since 2018, encompassing venture capital financing, secondary offerings, private placements, grants, debt financing, and other equity.

The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.

Key Benefits of Buying this Report

  • The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
  • Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with a pulse on the medical aesthetics market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Key Market Companies

  • ADSS
  • Allergan Aesthetics
  • Astiland, Beijing Kes Biological Technology
  • BTL Aesthetics
  • Candela Medical
  • Classys
  • Croma Pharma
  • Cynosure
  • Daeyang Medical
  • Establishment Labs
  • Galderma
  • Guangzhou Itech Aesthetics
  • IBSA
  • Lumenis
  • Lutronic
  • MedicalZone
  • Mentor
  • Sanhe Medical
  • Shanghai Haohai Biological Technology
  • Sinclair Pharma
  • Sincoheren
  • Skin Tech Pharma
  • Wontech
  • Zesay Beauty

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Introduction
  • 1.2. Project Objectives
  • 1.3. Scope of the Report
  • 1.4. Research Methodology
  • 1.5. Frequently Asked Questions
  • 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

  • 2.1. Chapter Overview
  • 2.2. Research Assumptions
  • 2.3. Project Methodology
  • 2.4. Forecast Methodology
  • 2.5. Robust Quality Control
  • 2.6. Key Market Segmentations
  • 2.7. Key Considerations
    • 2.7.1. Demographics
    • 2.7.2. Economic Factors
    • 2.7.3. Government Regulations
    • 2.7.4. Supply Chain
    • 2.7.5. COVID Impact / Related Factors
    • 2.7.6. Market Access
    • 2.7.7. Healthcare Policies
    • 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

  • 3.1. Chapter Overview
  • 3.2. Market Dynamics
    • 3.2.1. Time Period
      • 3.2.1.1. Historical Trends
      • 3.2.1.2. Current and Forecasted Estimates
    • 3.2.2. Currency Coverage
      • 3.2.2.1. Overview of Major Currencies Affecting the Market
      • 3.2.2.2. Impact of Currency Fluctuations on the Industry
    • 3.2.3. Foreign Exchange Impact
      • 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
      • 3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
    • 3.2.4. Recession
      • 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
      • 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
    • 3.2.5. Inflation
      • 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

  • 5.1. Chapter Overview
  • 5.2. Concept of Medical Aesthetics
  • 5.3. Evolution of Medical Aesthetics
  • 5.4. Types of Medical Aesthetic Procedures
    • 5.4.1. Non-invasive Procedures
      • 5.4.1.1. Facial Aesthetics
        • 5.4.1.1.1. Botulinum Toxin
        • 5.4.1.1.2. Dermal Fillers
        • 5.4.1.1.3. Chemical Peels
        • 5.4.1.1.4. Microdermabrasion
        • 5.4.1.1.5. Microneedling
        • 5.4.1.1.6. Thread Lift
      • 5.4.1.2. Body Contouring
      • 5.4.1.3. Hair Removal
        • 5.4.1.3.1. Intense Pulse Light Hair Removal
        • 5.4.1.3.2. Laser Hair Removal
      • 5.4.1.4. Tattoo Removal
      • 5.4.1.5. Nail Treatment
      • 5.4.1.6. Eyelash Treatment
      • 5.4.1.7. Permanent Make-up
    • 5.4.2. Invasive Procedures
      • 5.4.2.1. Breast Surgery
      • 5.4.2.2. Gluteal Implants
      • 5.4.2.3. Facial Surgery
      • 5.4.2.4. Liposuction
      • 5.4.2.5. Cosmetic Gynecology
  • 5.5. Advantages of Medical Aesthetics
  • 5.6. Side Effects of Medical Aesthetics
  • 5.7. Key Growth Drivers
  • 5.8. Emerging Technologies in Medical Aesthetics
    • 5.8.1. Virtual Reality in Medical Aesthetics
    • 5.8.2. Augmented Reality in Medical Aesthetics
    • 5.8.3. Artificial Intelligence in Medical Aesthetics
    • 5.8.4. Telemedicine in Medical Aesthetics
  • 5.9. Key Challenges of Medical Aesthetics
  • 5.10. Future Perspectives

6. MARKET LANDSCAPE

  • 6.1. Chapter Overview
  • 6.2. Medical Aesthetic Companies: Overall Market Landscape
    • 6.2.1. Analysis by Year of Establishment
    • 6.2.2. Analysis by Company Size
    • 6.2.3. Analysis by Location of Headquarters (Region)
    • 6.2.4. Analysis by Location of Headquarters (Country)
    • 6.2.5. Analysis by Year of Establishment and Location of Headquarters (Region)
    • 6.2.6. Analysis by Company Size and Location of Headquarters (Region)
    • 6.2.7. Analysis by Type of Offering
    • 6.2.8. Analysis by Type of Products and / or Devices Offered
    • 6.2.9. Analysis by Type of Facial Aesthetic Products and / or Devices Offered
    • 6.2.10. Analysis by Type of Body Contouring Products and / or Devices Offered
    • 6.2.11. Analysis by Type of Hair Removal Devices Offered
    • 6.2.12. Analysis by Type of Breast Aesthetic Products and / or Devices Offered
    • 6.2.13. Analysis by Application Area
    • 6.2.14. Analysis by Type of Procedure
    • 6.2.15. Analysis by End-user
    • 6.2.16. Analysis by Type of Products and / or Devices Offered and Location of Headquarters (Region)
    • 6.2.17. Analysis by Type of Procedure and Location of Headquarters (Region)

7. COMPANY PROFILES

  • 7.1. Chapter Overview
  • 7.2. Detailed Company Profiles of Key Players
    • 7.2.1. Companies Headquartered in North America
      • 7.2.1.1. Allergan Aesthetics
        • 7.2.1.1.1. Company Overview
        • 7.2.1.1.2. Financial Information
        • 7.2.1.1.3. Medical Aesthetics Portfolio
        • 7.2.1.1.4. Recent Developments and Future Outlook
      • 7.2.1.2. Candela Medical
        • 7.2.1.2.1. Company Overview
        • 7.2.1.2.2. Medical Aesthetics Portfolio
        • 7.2.1.2.3. Recent Developments and Future Outlook
      • 7.2.1.3. Cynosure
        • 7.2.1.3.1. Company Overview
        • 7.2.1.3.2. Medical Aesthetics Portfolio
        • 7.2.1.3.3. Recent Developments and Future Outlook
      • 7.2.1.4. Lutronic
        • 7.2.1.4.1. Company Overview
        • 7.2.1.4.2. Medical Aesthetics Portfolio
        • 7.2.1.4.3. Recent Developments and Future Outlook
      • 7.2.1.5. Mentor
        • 7.2.1.5.1. Company Overview
        • 7.2.1.5.2. Medical Aesthetics Portfolio
        • 7.2.1.5.3. Recent Developments and Future Outlook
    • 7.2.2. Companies Headquartered in Europe
      • 7.2.2.1. BTL Aesthetics
        • 7.2.2.1.1. Company Overview
        • 7.2.2.1.2. Medical Aesthetics Portfolio
        • 7.2.2.1.3. Recent Developments and Future Outlook
      • 7.2.2.2. Croma Pharma
        • 7.2.2.2.1. Company Overview
        • 7.2.2.2.2. Financial Information
        • 7.2.2.2.3. Medical Aesthetics Portfolio
        • 7.2.2.2.4. Recent Developments and Future Outlook
      • 7.2.2.3. Galderma
        • 7.2.2.3.1. Company Overview
        • 7.2.2.3.2. Financial Information
        • 7.2.2.3.3. Medical Aesthetics Portfolio
        • 7.2.2.3.4. Recent Developments and Future Outlook
      • 7.2.2.4. IBSA
        • 7.2.2.4.1. Company Overview
        • 7.2.2.4.2. Medical Aesthetics Portfolio
        • 7.2.2.4.3. Recent Developments and Future Outlook
      • 7.2.2.5. Sinclair Pharma
        • 7.2.2.5.1. Company Overview
        • 7.2.2.5.2. Medical Aesthetics Portfolio
        • 7.2.2.5.3. Recent Developments and Future Outlook
    • 7.2.3. Companies Headquartered in Asia-Pacific and Rest of the World
      • 7.2.3.1. Classys
        • 7.2.3.1.1. Company Overview
        • 7.2.3.1.2. Financial Information
        • 7.2.3.1.3. Medical Aesthetics Portfolio
        • 7.2.3.1.4. Recent Developments and Future Outlook
      • 7.2.3.2. Daeyang Medical
        • 7.2.3.2.1. Company Overview
        • 7.2.3.2.2. Medical Aesthetics Portfolio
        • 7.2.3.2.3. Recent Developments and Future Outlook
      • 7.2.3.3. Establishment Labs
        • 7.2.3.3.1. Company Overview
        • 7.2.3.3.2. Financial Information
        • 7.2.3.3.3. Medical Aesthetics Portfolio
        • 7.2.3.3.4. Recent Developments and Future Outlook
      • 7.2.3.4. Lumenis
        • 7.2.3.4.1. Company Overview
        • 7.2.3.4.2. Medical Aesthetics Portfolio
        • 7.2.3.4.3. Recent Developments and Future Outlook
      • 7.2.3.5. Shanghai Haohai Biological Technology
        • 7.2.3.5.1. Company Overview
        • 7.2.3.5.2. Financial Information
        • 7.2.3.5.3. Medical Aesthetics Portfolio
        • 7.2.3.5.4. Recent Developments and Future Outlook
  • 7.3. Short Profiles of Other Prominent Players
    • 7.3.1. ADSS
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Medical Aesthetics Portfolio
    • 7.3.2. Astiland
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Medical Aesthetics Portfolio
    • 7.3.3. Beijing Kes Biological Technology
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Medical Aesthetics Portfolio
    • 7.3.4. Guangzhou Itech Aesthetics 7.3.4.1.Company Overview
      • 7.3.4.2. Medical Aesthetics Portfolio
    • 7.3.5. MedicalZone
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Medical Aesthetics Portfolio
    • 7.3.6. Sanhe Medical
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Medical Aesthetics Portfolio
    • 7.3.7. Sincoheren
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Medical Aesthetics Portfolio
    • 7.3.8. Skin Tech Pharma
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Medical Aesthetics Portfolio
    • 7.3.9. Wontech
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Medical Aesthetics Portfolio
    • 7.3.10. Zesay Beauty
      • 7.3.10.1. Company Overview
      • 7.3.10.2. Medical Aesthetics Portfolio

8. COMPANY COMPETITIVENESS ANALYSIS

  • 8.1. Chapter Overview
  • 8.2. Key Assumptions and Parameters
  • 8.3. Methodology
  • 8.4. Medical Aesthetics: Company Competitiveness Analysis
    • 8.4.1. Companies based in North America
    • 8.4.2. Companies based in Europe
    • 8.4.3 Companies based in Asia-Pacific and Rest of the World

9. PARTNERSHIPS AND COLLABORATIONS

  • 9.1. Chapter Overview
  • 9.2. Partnership Models
  • 9.3. Medical Aesthetics: Partnerships and Collaborations
    • 9.3.1. Analysis by Year of Partnership
    • 9.3.2. Analysis by Type of Partnership
    • 9.3.3. Analysis by Year and Type of Partnership
    • 9.3.4. Analysis by Focus Area
    • 9.3.5. Most Active Players: Analysis by Number of Partnerships
  • 9.4. Analysis by Geography
    • 9.4.1. Local and International Agreements
    • 9.4.2. Intracontinental and Intercontinental Agreements

10. FUNDING AND INVESTMENTS

  • 10.1. Chapter Overview
  • 10.2. Funding Models
  • 10.3. Medical Aesthetics: Funding and Investments
    • 10.3.1. Analysis by Year of Funding
    • 10.3.2. Analysis by Amount Invested
    • 10.3.3. Analysis by Type of Funding
    • 10.3.4. Analysis by Year and Type of Funding
    • 10.3.5. Analysis by Type of Funding and Amount Invested
    • 10.3.6. Analysis by Geography
    • 10.3.7. Most Active Players
      • 10.3.7.1. Analysis by Number of Funding Instances
      • 10.3.7.2. Analysis by Amount Raised
    • 10.3.8. Leading Investors: Analysis by Number of Funding Instances
    • 10.3.9. Analysis by Company Size and Amount Invested
  • 10.4. Concluding Remarks

11. DELT ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Methodology
  • 11.3. Key Parameters
    • 11.3.1. Demographical Factors
    • 11.3.2. Environmental Factors
    • 11.3.3. Legal Factors
    • 11.3.4. Technological Factors
  • 11.4. Medical Aesthetics: DELT Analysis
    • 11.4.1. Allergan Aesthetics
    • 11.4.2. Candela
    • 11.4.3. Cutera
    • 11.4.4. Biotechitalia
    • 11.4.5. Sinclair Pharma
    • 11.4.6. Merz Pharma
    • 11.4.7. Dermosistemi
    • 11.4.8. Alma Lasers
    • 11.4.9. Bison Medical
  • 11.5. Conclusion

12. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

  • 12.1. Chapter Overview
  • 12.2. Market Drivers
  • 12.3. Market Restraints
  • 12.4. Market Opportunities
  • 12.5. Market Challenges
  • 12.6. Conclusion

13. GLOBAL MEDICAL AESTHETICS MARKET

  • 13.1. Chapter Overview
  • 13.2. Key Assumptions and Methodology
  • 13.3. Global Medical Aesthetics Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 13.3.1. Scenario Analysis
      • 13.3.1.1. Conservative Scenario Analysis
      • 13.3.1.2. Optimistic Scenario Analysis
  • 13.4. Key Market Segmentations
  • 13.5. Dynamic Dashboards

14. MEDICAL AESTHETICS MARKET, BY TYPE OF PRODUCT AND / OR DEVICE OFFERED

  • 14.1. Chapter Overview
  • 14.2. Key Assumptions and Methodology
  • 14.3. Medical Aesthetics Market: Distribution by Type of Product and / or Device Offered, 2018, 2023 and 2035
    • 14.3.1. Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.2. Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.3. Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.4. Body Contouring: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.5. Hair Removal: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.6. Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.7. Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.8. Other Products and / or Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 14.4. Data Triangulation and Validation

15. MEDICAL AESTHETICS MARKET, BY TYPE OF PROCEDURE

  • 15.1. Chapter Overview
  • 15.2. Key Assumptions and Methodology
  • 15.3. Medical Aesthetics Market: Distribution by Type of Procedure, 2018, 2023 and 2035
    • 15.3.1. Non-invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 15.3.2. Minimally Invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 15.3.3. Invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 15.4. Data Triangulation and Validation

16. MEDICAL AESTHETICS MARKET, BY END-USER

  • 16.1. Chapter Overview
  • 16.2. Key Assumptions and Methodology
  • 16.3. Medical Aesthetics Market: Distribution by End-user, 2018, 2023 and 2035
    • 16.3.1. Hospitals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

16.3.2.. Clinics / Med Spas and Dermatology / Cosmetology Centers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

    • 16.3.3. Other End-users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 16.4. Data Triangulation and Validation

17. MEDICAL AESTHETICS MARKET, BY GENDER

  • 17.1. Chapter Overview
  • 17.2. Key Assumptions and Methodology
  • 17.3. Medical Aesthetics Market: Distribution by Gender, 2018, 2023 and 2035
    • 17.3.1. Females: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.3.2. Males: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 17.4. Data Triangulation and Validation

18. MEDICAL AESTHETICS MARKET, BY DISTRIBUTION CHANNEL

  • 18.1. Chapter Overview
  • 18.2. Key Assumptions and Methodology
  • 18.3. Medical Aesthetics Market, by Distribution Channel, 2018, 2023 and 2035
    • 18.3.1. Direct Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 18.3.2. Indirect Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 18.4. Data Triangulation and Validation

19. MEDICAL AESTEHTICS MARKET, BY KEY GEOGRAPHICAL REGION

  • 19.1. Chapter Overview
  • 19.2. Key Assumptions and Methodology
  • 19.3. Medical Aesthetics Market: Distribution by Key Geographical Regions, 2019, 2023 and 2035
    • 19.3.1. North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.1.1. US: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.1.2. Canada: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.1.3. Mexico: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
    • 19.3.2. Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.2.1. UK: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.2.2. Germany: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.2.3. France: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.2.4. Italy: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.2.5. Spain: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.2.5. Rest of the Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
    • 19.3.3. Asia-Pacific: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.3.1. China: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.3.2. South Korea Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.3.3. Japan: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.3.4. India: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
    • 19.3.4. Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.4.1. Turkey: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.4.2. Iran: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.4.3. Rest of the Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
    • 19.3.5. Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.5.1. Brazil: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.5.2. Argentina: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
      • 19.3.5.3. Rest of the Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
  • 19.4. Data Triangulation and Validation

20. MEDICAL AESTHETICS PRODUCTS MARKET

  • 20.1. Chapter Overview
  • 20.2. Key Assumptions and Methodology
  • 20.3. Global Medical Aesthetics Products Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 20.3.1. Medical Aesthetics Products Market, by Type of Product Offered, 2018, 2023 and 2035
      • 20.3.1.1. Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.3.1.2. Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.3.1.3. Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.3.1.4. Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.3.1.5. Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 20.4.1. Medical Aesthetics Products Market, by Key Geographical Regions, 2018, 2023 and 2035
      • 20.4.1.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.4.1.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.4.1.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.4.1.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 20.4.1.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 20.5. Data Triangulation and Validation

21. EXECUTIVE INSIGHTS

22. CONCLUSION

23. APPENDIX 1: TABULATED DATA

24. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS